Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy

por Liu, Yifan, Cheng, Wenxu, Xin, HongYi, Liu, Ran, Wang, Qinqi, Cai, Wenqi, Peng, Xiaochun, Yang, Fuyuan, Xin, HongWu
Publicado 2023

Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy

por Wang, Xianwang, Shen, Yihua, Wan, Xingxia, Hu, Xiaoqing, Cai, Wen-Qi, Wu, Zijun, Xin, Qiang, Liu, Xiaoqing, Gui, Jingang, Xin, Hong-Yi, Xin, Hong-Wu
Publicado 2023

Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins

por Liu, Xiao-Qin, Xin, Hong-Yi, Lyu, Yan-Ning, Ma, Zhao-Wu, Peng, Xiao-Chun, Xiang, Ying, Wang, Ying-Ying, Wu, Zi-Jun, Cheng, Jun-Ting, Ji, Jia-Fu, Zhong, Ji-Xin, Ren, Bo-Xu, Wang, Xian-Wang, Xin, Hong-Wu
Publicado 2018

Identification of Putative UL54 (ICP27) Transcription Regulatory Sequences Binding to Oct-1, v-Myb, Pax-6 and Hairy in Herpes Simplex Viruses

por Wang, Ying-Ying, Lyu, Yan-Ning, Xin, Hong-Yi, Cheng, Jun-Ting, Liu, Xiao-Qin, Wang, Xian-Wang, Peng, Xiao-Chun, Xiang, Ying, Xin, Victoria W., Lu, Cheng-Biao, Ren, Bo-Xu, Liang, Yan-Fang, Ji, Jia-Fu, Ma, Zhaowu, Cui, Shu-Zhong, Xin, Hong-Wu
Publicado 2019